Management Sciences for Health Tag

  • All
  • Advocacy Hub
  • Advocacy Update
  • Blog Posts
  • GHC Announcements
  • News Center
  • Statement
Getting Local with Global Health Security: A Path Toward Sustainable Action

Organized by
May 21
4:00 PM – 6:00 PM CEST
Club Suisse de la Press, Route de Ferney 106
Geneva, Switzerland


*This event will be webcast live*

Protecting the world from infectious disease threats requires that national governments share the responsibility of serving those most in need, but how do countries prioritize their investments in a rapidly changing world?

On the margins of the 71st World Health Assembly, this event will convene global and national leaders for a discussion on how investments in global health security strengthen public health systems, promote universal health coverage, and drive economic growth and local research and development. This event will outline the best case for investment in health security, explore how to scale up innovative programming at the country level, and provide recommendations on increasing country ownership and domestic buy-in for health security.

Speakers will be as follows:

Moderator: Loyce Pace, President and Executive Director, Global Health Council

Opening Remarks: Dr. Tom Frieden, President and Chief Executive Officer, Vital Strategies.

Keynote Speaker: Peter Sands, Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria

1) Dr. Naoko Yamamoto, Assistant Director-General for Universal Health Coverage and Health Systems Cluster, World Health Organization (TBC)
2) Dr. Diane Gashumba, Minister of Health, Rwanda
3) Catharina Boehme, Chief Executive Officer, Foundation for Innovative New Diagnostics (FIND)

Closing Remarks: Marian W. Wentworth, President and Chief Executive Officer, Management Sciences for Health

Shortchanging Global Health Now Will Cost Us Later

This guest blog was originally posted on STAT News’s website. The blog was written by Ashley Arabasadi, Health Security Policy Adviser at Management Sciences for Health.  Management Sciences for Health (MSH) works shoulder-to-shoulder with countries and communities to save lives and improve the health of the world’s poorest and most vulnerable people by building strong, resilient, sustainable health systems. MSH is a 2018 Global Health Council member.

A council worker sprays disinfectant while cleaning up a market in Antananarivo, Madagascar, in October 2017 during an outbreak of plague. Rijasolo/AFP/Getty Images

The White House recently released a report outlining the progress and investments the U.S. has made to make the world safer from the threat of epidemics. But the key to epidemic preparedness and response is the Centers for Disease Control and Prevention, whose operations abroad will radically scale back due to looming funding cuts.

Every global health security expert warns us that it’s not a matter of whether the next deadly epidemic will happen, but when. Withdrawing global health funding now will virtually guarantee that any future outbreak will be far-reaching and economically disastrous; the World Bank estimates that an epidemic such as the 1918 Spanish Flu could cost as much as 5 percent of global GDP.

The CDC faces an 80 percent cut to global health security programs in 39 of the 49 countries in which the agency currently focuses, many considered hot spots for emerging infectious diseases. This could have a negative impact on the health, economy, and security of the U.S. The proposed cuts rightly drew an outcry from a number of health organizations and was thoroughly covered in the media.

In addition to stopping vital CDC programs, the funding cliff jeopardizes other U.S. investments in global health, such as those made through USAID. This money protects Americans at home and abroad, saves lives, strengthens fragile states, and promotes social and economic progress. Programs that invest in women and children, HIV, malaria, and other key areas create more resilient health systems that are the first line of defense against emerging disease threats.

As CDC Acting Director Anne Schuchat has said, “Here in the U.S., we rely on frontline health workers to detect and respond to health emergencies. But we can’t protect our citizens unless other countries can also protect theirs through strong investments in health systems.”

Health workers are indeed the frontline response mechanism for infectious disease outbreaks. And in many parts of the world, their work is supported by international donors, with the United States traditionally leading the pack.

Take Madagascar, which had a severe outbreak of plague last year. Thanks in part to a cadre of community health volunteers working with Madagascar’s authorities and, among other U.S. players, Management Sciences for Health — the nongovernmental organization where I work — a coordinated and swift local response quickly stopped the disease from spreading.

Past investments in HIV/AIDS have trained health workers and strengthened surveillance systems, laboratory networks, and biocontainment capabilities that helped to stop Ebola in its tracks in Nigeria and the Democratic Republic of Congo.

At this point, there should be little resistance to the notion that it is in our country’s interest to fund programs that detect and contain diseases at their source. After all, a pathogen can travel around the globe in as long as it takes to fly a plane from Liberia to Dallas.

The proposed CDC cuts will cost the U.S. much more down the road. The economic burden of epidemics is well-documented: massive expenditures, disrupted global business and supply chains, costly trade implications, and more. Ebola cost U.S. taxpayers a total of $5.4 billion, and it put American lives at risk.

The 2002-2003 outbreak of SARS, or severe acute respiratory syndrome, cost the global economy an estimated $40 billion. According to the World Bank, the next severe pandemic could cost the world economy up to $6 trillion. Additionally, global health security, which relies on the capacity of all countries to detect and control health threats, is critical to the U.S. economy and jobs.

Strategic investments in public and animal health and pandemic preparedness need to be a national security priority of governments and a key commitment from multilateral agencies, development banks, NGOs, academia, and private sector stakeholders worldwide.

When calculated in terms of lives lost, economic meltdowns, and global instability, infectious disease outbreaks can cause catastrophic losses when not stopped at the source. Doing that requires investing in the CDC and USAID, and the programs and people watching and working in vulnerable countries. Now is not the time to scale back.

MSH at the 48th Union World Conference on Lung Health

Organized by Management Sciences for Health (MSH)

Photo Credit: Warren Zelman

October 11 – 14
Expo Guadalajara
Guadalajara, Mexico


Registration for the conference is required to attend

Join MSH at the 48th Union World Conference on Lung Health in Guadalajara, Mexico, October 11-14. MSH staff from seven countries will be participating in a variety of symposia, workshops, posters, and oral presentations to share their experience and expertise on a range of topics that include drug procurement and safety; QuanTB, an electronic system designed to improve procurement processes, ordering, and supply planning for TB treatment; Urban DOTS implementation; MDR-TB program implementation; GeneXpert scale-up; contact investigation; the integration of TB and diabetes screening and treatment in Ethiopia and Afghanistan; the integration of TB testing networks; biosafety, and more.

Unpacking UHC Governance and Financing: Making Health for All a Reality

Organized by Management Sciences for Health

September 20
8:00 AM – 8:30 AM (Breakfast) & 8:30 AM – 10:00 AM (Program)
Harvard Club 35 W 44th Street
New York, New York


Globally, the focus in the health sector has shifted toward practical interventions toward achieving universal health coverage (UHC). Good governance at all levels is a cornerstone to achieving UHC. Financing reform is the other.

Please join MSH for a lively discussion on some innovative new country and regional initiatives on governance and financing that are working toward making health care affordable, accessible and equitable.


Organized by

July 24 – 26
12.30 P.M. – 2.30 P.M.
Palais des Congrès
Paris, France


Join us next week for the 9th International AIDS Society Conference on HIV Science in Paris, France. This year, we have an impressive lineup of poster presentations that showcase the inspiring and ambitious work MSH is doing to improve HIV treatment and care around the world, particularly in the Democratic Republic of the Congo, Malawi, Nigeria, and Swaziland.